Midland Wealth Advisors’s AbbVie ABBV Stock Holding History

Midland Wealth Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.81M	Sell	12,911 -493	-4%	-$109K	0.14%	36
2025 Q4	$3.06M	Sell	13,404 -1,792	-12%	-$408K	0.16%	34
2025 Q3	$3.52M	Buy	15,196 +1,009	+7%	+$205K	0.19%	34
2025 Q2	$2.63M	Sell	14,187 -110	-0.8%	-$20.4K	0.15%	32
2025 Q1	$3M	Sell	14,297 -1,121	-7%	-$218K	0.18%	30
2024 Q4	$2.74M	Buy	15,418 +45	+0.3%	+$8.27K	0.16%	36
2024 Q3	$3.04M	Sell	15,373 -2,407	-14%	-$449K	0.18%	31
2024 Q2	$3.05M	Buy	17,780 +421	+2%	+$69.7K	0.18%	35
2024 Q1	$3.16M	Buy	17,359 +596	+4%	+$103K	0.19%	29
2023 Q4	$2.6M	Buy	+16,763	New	+$2.44M	0.18%	31

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Midland Wealth Advisors's ABBV Position: Q1 2026 in Review

Midland Wealth Advisors reduced its AbbVie (ABBV) stake by 3.7% in Q1 2026, selling an estimated $109K and leaving 12,911 shares worth $2.81M. The position accounts for 0.14% of the portfolio, ranked #36.

Midland Wealth Advisors first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.52M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Midland Wealth Advisors held 12,911 shares of AbbVie worth $2.81M as of Q1 2026.
Midland Wealth Advisors sold 493 AbbVie shares in Q1 2026, an estimated $109K.
AbbVie made up 0.14% of Midland Wealth Advisors's portfolio in Q1 2026, its #36 holding.
Midland Wealth Advisors first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Midland Wealth Advisors's AbbVie position peaked at $3.52M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Midland Wealth Advisors's 13F filing for Q1 2026, filed 7 May 2026.